Key facts
- This page summarizes Mark Leonard Singleton's Form 4 filing for Bioventus Inc. (BVS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Jun 2024, 20:46.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
Footnote F2
The RSUs shall vest 50% on the twelve-month anniversary of the date of grant, and the remaining 50% shall vest on the eighteenth-month anniversary of the date of grant, subject to the Reporting Person continuing in service through the applicable vesting date.